巨噬细胞糖酵解在脓毒症中的研究进展

doi:10.3969/j.issn.1006-5725.2024.19.020

Abstract

Abstract:

Sepsis is a heterogeneous syndrome. It is caused by infections， attributing to immune dysfunction pathologically. The disease is characterized by macrophage-mediated inflammation and immune response throughout its development. During septic development， macrophages metabolize crucially with glycolysis remarkably enhanced. The glycolystic enhancement facilitates septic development by promoting the inflammatory response of macrophages and altering their phenotype. Therefore， direct or indirect inhibition of macrophagic glycolysis can alleviate sepsis and neutralize damages to organs functionally， promoting the polarization of anti-inflammatory phenotype. In this review， we aim to investigate the relationship between macrophagic glycolysis and sepsis， focusing on researching into relevant molecular mechanisms by which glycolysis is regulated for treating sepsis. It is concluded that interfering with macrophagic glycolysis may serve as a novel therapeutic strategy for treating sepsis.

Key words: sepsis, macrophage, glycolysis

CLC Number:

R459.7

Xing CAI,Xinglong MA,Changjian ZHOU,Peng XIE,Songxuan SHEN,Yanmei MIAO,Jiamei SONG,Leiyu. XIE. The research progress of macrophage glycolysis in sepsis[J]. The Journal of Practical Medicine, 2024, 40(19): 2783-2788.

Figures/Tables 2

References 38

1	SINGER M， DEUTSCHMAN C S， SEYMOUR C W， et al. The Third International Consensus Definitions for Sepsis and Septic Shock （Sepsis-3）［J］. JAMA， 2016， 315（8）：801-810. doi:10.1001/jama.2016.0287 doi: 10.1001/jama.2016.0287
2	WANG Z， KONG L， TAN S， et al. Zhx2 Accelerates Sepsis by Promoting Macrophage Glycolysis via Pfkfb3［J］. J Immunol， 2020， 204（8）：2232-2241. doi:10.4049/jimmunol.1901246 doi: 10.4049/jimmunol.1901246
3	蒋龙元. 免疫紊乱在脓毒症中的作用［J］. 实用医学杂志， 2021，37（6）：701-704. doi:10.3969/j.issn.1006-5725.2021.06.001 doi: 10.3969/j.issn.1006-5725.2021.06.001
4	CHEN X， LIU Y， GAO Y， et al. The roles of macrophage polarization in the host immune response to sepsis［J］. Int Immunopharmacol， 2021， 96：107791. doi:10.1016/j.intimp.2021.107791 doi: 10.1016/j.intimp.2021.107791
5	MINHAS P S， LATIF-HERNANDEZ A， MCREYNOLDS M R， et al. Restoring metabolism of myeloid cells reverses cognitive decline in ageing［J］. Nature， 2021，590（7844）：122-128. doi:10.1038/s41586-020-03160-0 doi: 10.1038/s41586-020-03160-0
6	CHANDEL N S. Glycolysis［J］. Cold Spring Harb Perspect Biol， 2021，13（5）：a040535. doi:10.1101/cshperspect.a040535 doi: 10.1101/cshperspect.a040535
7	CHANG Y C， KIM C H. Molecular Research of Glycolysis［J］. Int J Mol Sci， 2022，23（9）：5052. doi:10.3390/ijms23095052 doi: 10.3390/ijms23095052
8	FREEMERMAN A J， ZHAO L， PINGILI A K， et al. Myeloid Slc2a1-Deficient Murine Model Revealed Macrophage Activation and Metabolic Phenotype Are Fueled by GLUT1［J］. J Immunol， 2019， 202（4）：1265-1286. doi:10.4049/jimmunol.1800002 doi: 10.4049/jimmunol.1800002
9	GAUTHIER T， CHEN W. Modulation of Macrophage Immunometabolism： A New Approach to Fight Infections［J］. Front Immunol，2022，13：780839. doi:10.3389/fimmu.2022.780839 doi: 10.3389/fimmu.2022.780839
10	KIERANS S J， TAYLOR C T. Regulation of glycolysis by the hypoxia‐inducible factor （HIF）： Implications for cellular physiology［J］. J Physiol， 2021， 599（1）：23-37. doi:10.1113/jp280572 doi: 10.1113/jp280572
11	ROQUILLY A， MCWILLIAM H E G， JACQUELINE C， et al. Local Modulation of Antigen-Presenting Cell Development after Resolution of Pneumonia Induces Long-Term Susceptibility to Secondary Infections［J］. Immunity， 2017， 47（1）：135-147.e5. doi:10.1016/j.immuni.2017.06.021 doi: 10.1016/j.immuni.2017.06.021
12	FREEMERMAN A J， JOHNSON A R， SACKS G N， et al. Metabolic Reprogramming of Macrophages［J］. J Biol Chem， 2014， 289（11）：7884-7896. doi:10.1074/jbc.m113.522037 doi: 10.1074/jbc.m113.522037
13	吴长江. 脓毒症的病理生理机制及其诊疗研究进展［J］. 智慧健康， 2022，8（8）：29-36.
14	ZINKERNAGEL A S， JOHNSON R S， NIZET V. Hypoxia inducible factor （HIF） function in innate immunity and infection［J］. J Mol Med， 2007， 85（12）：1339-1346. doi:10.1007/s00109-007-0282-2 doi: 10.1007/s00109-007-0282-2
15	CHEN X， LIU Y， GAO Y， et al. The roles of macrophage polarization in the host immune response to sepsis［J］. Int Immunopharmacol， 2021， 96：107791. doi:10.1016/j.intimp.2021.107791 doi: 10.1016/j.intimp.2021.107791
16	DENG H， WU L， LIU M， et al. Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Attenuate LPS-Induced ARDS by Modulating Macrophage Polarization Through Inhibiting Glycolysis in Macrophages［J］. Shock， 2020， 54（6）：828-843. doi:10.1097/shk.0000000000001549 doi: 10.1097/shk.0000000000001549
17	DENG H， WU L， LIU M， et al. Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Attenuate LPS-Induced ARDS by Modulating Macrophage Polarization Through Inhibiting Glycolysis in Macrophages［J］. Shock， 2020， 54（6）：828-843. doi:10.1097/shk.0000000000001549 doi: 10.1097/shk.0000000000001549
18	IWASAKI A， MEDZHITOV R. Control of adaptive immunity by the innate immune system［J］. Nat Immunol， 2015， 16（4）：343-353. doi:10.1038/ni.3123 doi: 10.1038/ni.3123
19	YANG L， XIE M， YANG M， et al. PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis［J］. Nat Commun， 2014， 5：4436. doi:10.1038/ncomms5436 doi: 10.1038/ncomms5436
20	YUAN Y， FAN G， LIU Y， et al. Correction to： The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis［J］. Cell Mol Immunol， 2022，19（5）：650. doi:10.1038/s41423-022-00839-4 doi: 10.1038/s41423-022-00839-4
21	REINFELD B I， MADDEN M Z， WOLF M M， et al. Cell Programmed Nutrient Partitioning in the Tumor Microenvironment［J］. Nature，2021， 593（7858）：282-288. doi:10.1038/s41586-021-03442-1 doi: 10.1038/s41586-021-03442-1
22	NOLT B， TU F， WANG X， et al. Lactate and Immunosuppression in Sepsis［J］. Shock， 2018， 49（2）：120-125. doi:10.1097/shk.0000000000000958 doi: 10.1097/shk.0000000000000958
23	NEAGU M. Metabolic Traits in Cutaneous Melanoma［J］. Front Oncol， 2020，10：851. doi:10.3389/fonc.2020.00851 doi: 10.3389/fonc.2020.00851
24	HAYES C， DONOHOE C L， DAVERN M， et al. The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment［J］. Cancer Lett， 2021， 500：75-86. doi:10.1016/j.canlet.2020.12.021 doi: 10.1016/j.canlet.2020.12.021
25	SCHOUWENBURG M G， SUIJKERBUIJK K P M， KOORNSTRA R H T， et al. Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy； The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH？［J］.Cancers， 2019， 11（12）：1940. doi:10.3390/cancers11121940 doi: 10.3390/cancers11121940
26	ZHANG Z， LI Y， YAN X， et al. Pretreatment lactate dehydrogenase may predict outcome of advanced non small‐cell lung cancer patients treated with immune checkpoint inhibitors： A meta‐analysis［J］. Cancer Med， 2019， 8（4）：1467-1473. doi:10.1002/cam4.2024 doi: 10.1002/cam4.2024
27	VAUPEL P， MULTHOFF G. Fatal Alliance of Hypoxia-/HIF-1α- Driven Microenvironmental Traits Promoting Cancer Progression［J］. Adv Exp Med Biol， 2020， 1232：169-176. doi:10.1007/978-3-030-34461-0_21 doi: 10.1007/978-3-030-34461-0_21
28	LEMBERG K M， GORI， S S， TSUKAMOTO T， et al. Clinical development of metabolic inhibitors for oncology［J］. J Clin Invest，2022，132（11）：e151895. doi:10.1172/jci148550 doi: 10.1172/jci148550
29	CHELAKKOT C， CHELAKKOT V S， SHIN Y， et al. Modulating Glycolysis to Improve Cancer Therapy［J］. Int J Mol Sci， 2023，24（3）：2606. doi:10.3390/ijms24032606 doi: 10.3390/ijms24032606
30	BLOUIN C C， LPAGÉ E， SOUCY G M， et al. Hypoxic gene activation by lipopolysaccharide in macrophages： implication of hypoxia-inducible factor 1alpha［J］. Blood， 2004， 103（3）：1124-1130. doi:10.1182/blood-2003-07-2427 doi: 10.1182/blood-2003-07-2427
31	MAGER C E， MORMOL J M， SHELTON E D， et al. p38 MAPK and MKP-1 control the glycolytic program via the bifunctional glycolysis regulator PFKFB3 during sepsis［J］. J Biol Chem， 2023， 299（4）：103043. doi:10.1016/j.jbc.2023.103043 doi: 10.1016/j.jbc.2023.103043
32	HE Q， YIN J， ZOU B， et al. WIN55212-2 alleviates acute lung injury by inhibiting macrophage glycolysis through the miR-29b-3p/FOXO3/PFKFB3 axis［J］. Mol Immunol， 2022， 149：119-128. doi:10.1016/j.molimm.2022.06.005 doi: 10.1016/j.molimm.2022.06.005
33	PALSSON-MCDERMOTT E M， CURTIS A M， GOEL G， et al. Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and is a critical determinant of the warburg effect in LPS-activated macrophages［J］. Cell Metab， 2015， 21（2）：65-80. doi:10.1016/j.cmet.2014.12.005 doi: 10.1016/j.cmet.2014.12.005
34	PEI L， LE Y， CHEN H， et al. Cynaroside prevents macrophage polarization into pro-inflammatory phenotype and alleviates cecal ligation and puncture-induced liver injury by targeting PKM2/HIF-1α axis［J］. Fitoterapia， 2021， 152：104922. doi:10.1016/j.fitote.2021.104922 doi: 10.1016/j.fitote.2021.104922
35	DING H， WANG J J， ZHANG X Y， et al. Lycium barbarum Polysaccharide Antagonizes LPS-Induced Inflammation by Altering the Glycolysis and Differentiation of Macrophages by Triggering the Degradation of PKM2［J］. Biol Pharm Bull， 2021， 44（3）：379-388. doi:10.1248/bpb.b20-00752 doi: 10.1248/bpb.b20-00752
36	PAN L， HU L， ZHANG L， et al. Deoxyelephantopin decreases the release of inflammatory cytokines in macrophage associated with attenuation of aerobic glycolysis via modulation of PKM2［J］. Int Immunopharmacol， 2020， 79：106048.
37	CRAMER T， YAMANISHI Y， CLAUSEN B E， et al. HIF-1α is essential for myeloid cell-mediated inflammation［J］. Cell， 2003， 112（5）：645-657. doi:10.1016/s0092-8674(03)00154-5 doi: 10.1016/s0092-8674(03)00154-5
38	SHIN M K， DRAGER L F， YAO Q， et al. Metabolic Consequences of High-Fat Diet Are Attenuated by Suppression of HIF-1α［J］. PLoS One， 2012，7（10）：e46562. doi:10.1371/journal.pone.0046562 doi: 10.1371/journal.pone.0046562

[1]	Xianqi WANG,Bin ZHANG,Qi ZHANG,Zheng DAI,Jinxin ZHANG,Xiaoli LIANG,Lin LI,Lin WU,Shanshou LIU. Analysis of the changes in the count and function of platelet at the early sepsis based on single cell sequencing [J]. The Journal of Practical Medicine, 2024, 40(9): 1218-1224.
[2]	Yong LIU,XiaoLei CHENG,Xiangli CUI,Hao TANG,Huanzhen CHEN. ROBO3 deficiency promotes chemotherapy⁃induced transition of macrophage to foam cell [J]. The Journal of Practical Medicine, 2024, 40(6): 787-795.
[3]	Junling WANG,Mengmeng ZHAN,Zhaolong ZHANG,Shaoheng HE,Bingyu. QIN. The research progress of the actions of mast cells in sepsis [J]. The Journal of Practical Medicine, 2024, 40(5): 596-600.
[4]	Jiadong WANG,Fangzhou HUANG,Yan HUANG,Guanxiong CHEN,Jun LIU,Peiqi. HUANG. Role of eupatilin in protection of mitochondrial function through Sesn2⁃Nrf2 in septic brain injury [J]. The Journal of Practical Medicine, 2024, 40(5): 601-607.
[5]	Ying ZHOU,Dajun JIANG,Yong TIAN,Yongxiang GU,Guohui. YANG. Inhibition of TRAF6 ameliorates myocardial inflammatory injury and cardiac dysfunction via regulating cardiomyocyte inflammation in sepsis mice [J]. The Journal of Practical Medicine, 2024, 40(5): 608-614.
[6]	Bo YANG,Zhaoquan. JIN. The clinical efficacy of sivelestat sodium combined with ulinastatin for sepsis⁃induced acute respiratory distress syndrome [J]. The Journal of Practical Medicine, 2024, 40(5): 621-626.
[7]	Guangping WU,Xin YIN,Jianzhuo HE,Liheng. GUO. The effect of Xinmailong injection on microcirculation in patients with septic shock [J]. The Journal of Practical Medicine, 2024, 40(5): 627-631.
[8]	Aiqin LI,Zhen ZHANG,Ya′nan XU,Jinyuan ZHU,Xu. ZHANG. Research progress on the interaction between macro⁃phages and fibroblasts in ARDS pulmonary fibrosis [J]. The Journal of Practical Medicine, 2024, 40(4): 571-574.
[9]	Chengcai DAI,Zhenxing CHENG,Qianqian TU. The prognostic value of serum cystatin C combined with bedside renal ultrasound in patients with sepsis⁃induced acute kidney injury [J]. The Journal of Practical Medicine, 2024, 40(22): 3226-3231.
[10]	Xing CHEN,Yan DENG. The role of glutamine metabolic reprogramming in macrophages in cardiovascular disease [J]. The Journal of Practical Medicine, 2024, 40(22): 3262-3267.
[11]	Yuliang HUANG,Ying TANG,Wenjuan YU,Junzhe. CHEN. The mechanism of cyclin D1 ameliorates renal ischemia⁃reperfusion⁃induced acute kidney injury by promotingglycolysis [J]. The Journal of Practical Medicine, 2024, 40(21): 3013-3022.
[12]	Linlin GAI,Weice SUN,Jinjin CHU,Donghua XU. Changes of M1/M2 macrophages polarization associated with active pulmonary tuberculosis and the effect of ESAT6 on macrophage polarization [J]. The Journal of Practical Medicine, 2024, 40(20): 2867-2873.
[13]	Zhouyou WU,Ting LI,Tengwei ZHANG,Qiaoyan FANG,Liu YANG,Qiao LI. Hydroxynonenal alleviates neonatal sepsis⁃induced acute lung injury by inhibiting endothelial cell pyrosis [J]. The Journal of Practical Medicine, 2024, 40(2): 195-201.
[14]	Fangmin GENG,Yuandan HE,Wenjuan LI,Qianqian LIU,Hongwei ZHANG,Zhangping LU,Lianhua WEI. Values of different DIC scoring systems in early diagnosis and prognosis prediction of coagulation dysfunction in sepsis patients [J]. The Journal of Practical Medicine, 2024, 40(2): 248-252.
[15]	Jianbo YANG,Jichun SHAO,Zhijun ZENG,Tao ZHAO,Xing. WANG. Effect of lncRNA MIF⁃AS1 on the malignant biological behavior of prostate cancer cells by regulating the miR⁃423⁃5p/PYCR1 axis [J]. The Journal of Practical Medicine, 2024, 40(18): 2544-2549.

The research progress of macrophage glycolysis in sepsis

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 38

Related Articles 15

Recommended Articles

Metrics

Comments